Song David H, Wu Liza C, Lohman Robert F, Gottlieb Lawrence J, Franczyk Mieczyslawa
Section of Plastic and Reconstructive Surgery, University of Chicago Hospitals, Ill 60637, USA.
Plast Reconstr Surg. 2003 Jan;111(1):92-7. doi: 10.1097/01.PRS.0000037686.14278.6A.
A method to refine the treatment of sternal wounds using Vacuum Assisted Closure (V.A.C.) therapy as the bridge between débridement and delayed definitive closure is described. A retrospective review of 35 consecutive patients with sternal wound complications over a 2-year period (March of 1999 to March of 2001) was performed. The treatment of sternal wounds with traditional twice-a-day dressing changes was compared with the treatment with the wound V.A.C. device. An analysis of the number of days between initial débridement and closure, number of dressing changes, number and types of flaps needed for reconstruction, and complications was performed. Eighteen patients were treated with traditional twice-a-day dressing changes and 17 patients were treated with V.A.C. therapy alone. The two groups were similar regarding age, sex, type of cardiac procedure, and type of sternal wound. The V.A.C. therapy group had a trend toward a shorter interval between débridement and closure, with a mean of 6.2 days, whereas the dressing change group had mean of 8.5 days. The V.A.C. therapy group had a significantly lower number of dressing changes, with a mean of three, whereas the twice-a-day dressing change group had a mean of 17 (p < 0.05). Reconstruction required an average of 1.5 soft-tissue flaps per patient treated with traditional dressing changes versus 0.9 soft-tissue flaps per patient for those treated with V.A.C. therapy (p < 0.05). Before closure, there was one death among patients undergoing dressing changes and three in the V.A.C. therapy group, all of which were unrelated to the management of the sternal wound. Patients with sternal wounds who have benefited from V.A.C. therapy alone have a significant decrease in the number of dressing changes and number of soft-tissue flaps needed for closure. Finally, the V.A.C. therapy group had a trend toward a decreased number of days between débridement and closure.
描述了一种使用负压封闭引流(V.A.C.)疗法优化胸骨伤口治疗的方法,该疗法作为清创术与延迟确定性闭合之间的桥梁。对连续35例在2年期间(1999年3月至2001年3月)出现胸骨伤口并发症的患者进行了回顾性研究。将传统的每日两次换药治疗胸骨伤口与使用伤口V.A.C.装置治疗进行比较。分析了初次清创与闭合之间的天数、换药次数、重建所需皮瓣的数量和类型以及并发症情况。18例患者采用传统的每日两次换药治疗,17例患者仅采用V.A.C.疗法治疗。两组在年龄、性别、心脏手术类型和胸骨伤口类型方面相似。V.A.C.疗法组清创与闭合之间的间隔时间有缩短趋势,平均为6.2天,而换药组平均为8.5天。V.A.C.疗法组的换药次数明显较少,平均为3次,而每日两次换药组平均为17次(p<0.05)。采用传统换药治疗的患者平均每人需要1.5个软组织皮瓣进行重建,而采用V.A.C.疗法治疗的患者平均每人需要0.9个软组织皮瓣(p<0.05)。在闭合前,换药组有1例患者死亡,V.A.C.疗法组有3例患者死亡,所有死亡均与胸骨伤口的处理无关。仅接受V.A.C.疗法治疗的胸骨伤口患者的换药次数和闭合所需软组织皮瓣数量显著减少。最后,V.A.C.疗法组清创与闭合之间的天数有减少趋势。